Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jul;33(4):e13434.
doi: 10.1111/dth.13434. Epub 2020 May 5.

COVID-19 and psoriasis: Should we fear for patients treated with biologics?

Paolo Amerio  1 , Francesca Prignano  2 , Federica Giuliani  1 , Giulio Gualdi  1
Affiliations
Review

COVID-19 and psoriasis: Should we fear for patients treated with biologics?

Paolo Amerio et al. Dermatol Ther. 2020 Jul.

Abstract

The new coronavirus pandemic poses question and challenges for dermatologists. One of question is if psoriasis patients treated with immunomodulating and immunosuppressive drugs have to discontinue their treatment in the midst of fears for the infection and its consequences. One of the challenges is how can we support our patients in this critical time. Previous coronaviruses outbreaks reports, current published evidences on pathogenesis and on clinical reports of COVID infection in immunosuppressed patients are used to make a scientifically based decision.

Keywords: COVID-19; SARS; biologics; psoriasis; therapy.

PubMed Disclaimer

References

    1. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Evaluation and Treatment Coronavirus (COVID‐19). StatPearls . Treasure Island, Florida: StatPearls Publishing; 2020, 2020. Mar 20.
    1. Worldometers . COVID‐19 Coronavirus pandemic. Available at: https://www.worldometers.info/coronavirus/ (last access April 25, 2020)
    1. De Simone C, Amerio P, Amoruso G, et al. Immunogenicity of anti‐TNFα therapy in psoriasis: a clinical issue? Expert Opin Biol Ther. 2013;13:1673‐1682. - PubMed
    1. Conforti C, Giuffrida R, Dianzani C, Di Meo N, Zalaudek I. COVID‐19 and psoriasis: is it time to limit treatment with immunosuppressants? A call for action. Dermatol Ther. 2020;e13298. 10.1111/dth.13298. - DOI - PMC - PubMed
    1. Choudhry H, Bakhrebah MA, Abdulaal WA, et al. Middle East respiratory syndrome: pathogenesis and therapeutic developments. Future Virol. 2019;14:237‐246. - PMC - PubMed

MeSH terms

Substances